Cafepharma Today

February 11 2025 - Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
Wegovy and Ozempic stars dim amid overuse concerns
Ten years on, Roche jettisons InterMune and Esbriet in US
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Big Pharma's R&D Model Is Broken
Motley Fool
Thursday, March 26, 2009 - 4:47pm
tags:
Big Pharma, R&D
Elan, Biogen climb in wake of Tysabri presentation
Marketwatch
Thursday, March 26, 2009 - 2:47pm
tags:
Elan, Biogen Idec, Tysabri
Bristol-Myers, Novo Nordisk diabetes drugs face FDA review, while Amylin preps for application
Yahoo/AP
Thursday, March 26, 2009 - 2:46pm
tags:
Bristol-Myers Squibb, Novo Nordisk, FDA, Amylin, Alkermes, saxagliptin, Byetta
5-Star Stocks Poised to Pop: Novo Nordisk
Motley Fool
Thursday, March 26, 2009 - 2:45pm
tags:
Novo Nordisk, diabetes
VaxGen Still Looking to Return Value to Its Stockholders
Seeking Alpha
Thursday, March 26, 2009 - 9:12am
tags:
VaxGen
U.S. Prescription Drug Sales Grow Slowly; Hydrocodone Most Prescribed
Seeking Alpha
Thursday, March 26, 2009 - 9:01am
tags:
prescription data, hydrocodone
Economy nips, tucks plastic surgery business in 2008, but Botox injections grow
Yahoo/AP
Thursday, March 26, 2009 - 7:52am
tags:
Botox, Allergan
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Yahoo
Thursday, March 26, 2009 - 7:50am
tags:
Spectrum Pharmaceuticals, Fusilev, colon cancer, sNDA, FDA
Wyeth wins expanded indication for Tygacil
Fierce Pharma
Thursday, March 26, 2009 - 7:49am
tags:
Wyeth, Tygacil, FDA, pneumonia
Psychiatrists to Stop Taking Meeting Money From Drug Makers
WSJ Online
Thursday, March 26, 2009 - 7:14am
tags:
physician payments, APA
Neurocrine's Elagolix Misses Main Study Goal
TheStreet.com
Thursday, March 26, 2009 - 7:11am
tags:
Neurocrine, Elagolix, endometriosis, drug trials
Epix Pharmaceuticals auditors raise doubt about company's ability to stay in business
Yahoo/AP
Thursday, March 26, 2009 - 7:11am
tags:
Epix
Novo Nordisk’s Drug May Avoid Takeda’s FDA Travails
Bloomberg
Thursday, March 26, 2009 - 7:09am
tags:
Novo Nordisk, FDA, Takeda, diabetes, liraglutide
Biodel shares jump on plans to ask FDA for rapid-acting insulin approval in 2009
Yahoo/AP
Thursday, March 26, 2009 - 6:11am
tags:
insulin, diabetes, Biodel, Viaject
The FDA Leaves Pfizer in the Waiting Room
Motley Fool
Thursday, March 26, 2009 - 6:09am
tags:
FDA, Pfizer, Ligand, osteoporosis, Europe, Fablyn
Glaxo May Buy Large Stake in Generic-Maker Aspen: Report
TheStreet.com
Thursday, March 26, 2009 - 6:09am
tags:
GSK, Aspen, generics
Roche Wins Sufficient Shares to Complete Genentech Acquisition
Bloomberg
Thursday, March 26, 2009 - 6:08am
tags:
Roche, Genentech, buyouts
With Spectrum, Zevalin Might Finally Have a Chance
TheStreet.com
Wednesday, March 25, 2009 - 4:11pm
tags:
Spectrum Pharmaceuticals, Zevalin, cancer
Allos Submits Pralatrexate for FDA Approval
TheStreet.com
Wednesday, March 25, 2009 - 4:09pm
tags:
Allos, Pralatrexate, FDA, cancer
Auxilium Looks Toward Profits
Yahoo/Zacks.com
Wednesday, March 25, 2009 - 3:47pm
tags:
Auxilium, Xiaflex

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

The Continuing NIH/NSF Crisis, Part III: Indirect Costs
In the Pipeline
Vaccines Through Protein Degradation
In the Pipeline
Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information